Biosig Technologies, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
BioSig Technologies files an amendment to its Form S-1 registration statement for the resale of up to 1,680,631 shares of common stock issuable upon the exercise of outstanding warrants.
BioSig Technologies is registering for resale up to 1,680,631 shares of its common stock by selling stockholders, which are issuable upon the exercise of outstanding warrants.